GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.28 Billion | 994.69 Million | 854.22 Million | 1.1 Billion | 1.21 Billion | 1.61 Billion |
| Cost of Revenue | 347.41 Million | 344.84 Million | 331.48 Million | 319 Million | 270.37 Million | 305.69 Million |
| Gross Profit | 936.59 Million | 649.84 Million | 522.73 Million | 790.42 Million | 946.72 Million | 1.31 Billion |
| Operating Expenses | 818.48 Million | 990.51 Million | 895.29 Million | 698.38 Million | 721.21 Million | 806.9 Million |
| Selling, General and Administrative Expenses | 760.83 Million | 880.3 Million | 815.83 Million | 622 Million | 582.98 Million | 669.8 Million |
| Research and Development Expenses | 31.38 Million | 28.96 Million | 25.19 Million | 43.44 Million | 62.7 Million | 58.44 Million |
| Other Expenses | 26.26 Million | 81.25 Million | 54.26 Million | 32.94 Million | 75.52 Million | -5.96 Million |
| Cost and Expenses | 1.16 Billion | 1.33 Billion | 1.22 Billion | 1.01 Billion | 991.58 Million | 1.11 Billion |
| Operating Income | 114.81 Million | -340.67 Million | -372.55 Million | 108.86 Million | 241.45 Million | 458.18 Million |
| Interest Expense | 150.81 Thousand | 25.81 Million | 30.24 Million | 29.98 Million | 34.39 Million | 14.96 Million |
| Income Tax Expense | 7.52 Million | -2.12 Million | -20.19 Million | -12.06 Million | 20.62 Million | 58.16 Million |
| Earnings before Tax | 100.37 Million | -419.98 Million | -352.62 Million | 17.5 Million | 157.97 Million | 452.21 Million |
| Net Income | 90.07 Million | -417.85 Million | -332.42 Million | 32 Million | 130.06 Million | 374.1 Million |
| Earnings Per Share Basic | 0.18 | -0.85 | -0.68 | 0.07 | 0.27 | 1.06 |
| Earnings Per Share Diluted | 0.18 | -0.85 | -0.68 | 0.07 | 0.27 | 1.06 |
| Weighted Average Shares Outstanding | 500.43 Million | 489.49 Million | 489.49 Million | 489.49 Million | 489.49 Million | 352.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 500.43 Million | 489.49 Million | 489.49 Million | 489.49 Million | 489.49 Million | 352.93 Million |
| Gross Margin | 0.73 | 0.65 | 0.61 | 0.71 | 0.78 | 0.81 |
| EBIT Margin | 0.12 | -0.30 | -0.37 | 0.13 | 0.22 | 0.32 |
| Profit Margin | 0.07 | -0.42 | -0.39 | 0.03 | 0.11 | 0.23 |
| EBITDA | 157.93 Million | -200.54 Million | -316.34 Million | 44.06 Million | 206.53 Million | 514.89 Million |
| Earnings Before Tax Margin | 0.09 | -0.34 | -0.44 | 0.10 | 0.20 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 233.92 Million | 311.85 Million | 343.37 Million | 1.28 Billion | 313.54 Million | 273.95 Million |
| Cost of Revenue | 68.18 Million | 85.31 Million | 82.87 Million | 347.41 Million | 89 Million | 71.22 Million |
| Gross Profit | 165.74 Million | 226.54 Million | 260.5 Million | 936.59 Million | 224.54 Million | 202.72 Million |
| Operating Expenses | 187.35 Million | 220.03 Million | 194.85 Million | 779.71 Million | 182.45 Million | 194.98 Million |
| Selling, General and Administrative Expenses | 268.63 Million | 211.9 Million | 178.82 Million | - | 114.42 Million | 211.49 Million |
| Research and Development Expenses | 9.97 Million | 8.12 Million | 8.98 Million | - | 6.95 Million | 8.4 Million |
| Other Expenses | -91.24 Million | -13.21 Thousand | -8.09 Million | -31.37 Million | -39.39 Million | 13.12 Million |
| Cost and Expenses | 255.54 Million | 305.34 Million | 277.73 Million | 1.12 Billion | 271.46 Million | 266.21 Million |
| Operating Income | 16.17 Million | 6.5 Million | 62.23 Million | 114.81 Million | 18.56 Million | 4.96 Million |
| Interest Expense | 5.83 Million | 3.29 Million | 2.34 Million | - | -11.11 Million | 2.61 Million |
| Income Tax Expense | 5.02 Million | -232.84 Thousand | 4.5 Million | 7.52 Million | -3.12 Million | 3.32 Million |
| Earnings before Tax | 16.77 Million | 18.83 Million | 54.13 Million | 100.37 Million | -3.88 Million | 18.08 Million |
| Net Income | 11.36 Million | 18.29 Million | 41.3 Million | 90.07 Million | -1.47 Million | 14.42 Million |
| Earnings Per Share Basic | 0.02 | 0.04 | 0.08 | - | -0.00 | 0.03 |
| Earnings Per Share Diluted | 0.02 | 0.04 | 0.08 | - | -0.00 | 0.03 |
| Weighted Average Shares Outstanding | 489.49 Million | 489.49 Million | 489.37 Million | 500.43 Million | 532.51 Million | 489.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 489.49 Million | 489.49 Million | 489.37 Million | 500.43 Million | 532.51 Million | 489.49 Million |
| Gross Margin | 0.71 | 0.73 | 0.76 | 0.73 | 0.72 | 0.74 |
| EBIT Margin | 0.10 | 0.06 | 0.16 | - | 0.02 | 0.08 |
| Profit Margin | 0.05 | 0.06 | 0.12 | 0.07 | -0.00 | 0.05 |
| EBITDA | 22.61 Million | 18.34 Million | 56.47 Million | - | 5.36 Million | 20.69 Million |
| Earnings Before Tax Margin | 0.07 | 0.02 | 0.18 | 0.09 | 0.06 | 0.02 |
TRCK
8295
688038
SUDARSCHEM
600516
CLS-B